RelB is a potential molecular biomarker for immunotherapy in human pan-cancer

Introduction: The nuclear factor kB (NF-κB) pathway emerges as a critical regulator of immune responses and is often dysregulated in human cancers. It consists of a family of transcription factors involved in many biological responses. Activated NF-κB subunits results in the nuclear translocation an...

Full description

Bibliographic Details
Main Authors: Jintao Wu, Xinyu Yu, Hongyu Zhu, Peng Chen, Tongyan Liu, Rong Yin, Yan Qiang, Lin Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1178446/full